Introduction to Homologous Recombination Deficiency assessment

27 July 2022

This educational video explores main concepts of homologous recombination deficiency (HRD) and different testing approaches. HRD is a mutational signature utilized in the field of precision Oncology, frequently with ovarian, breast, prostate and pancreatic tumors. Learn more about Comprehensive Genomic Profiling at © 2022 Illumina, Inc. All rights reserved. M-GL-00821 Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on